top of page
Bringing
Genetic testing & Counselling to Nigeria
A novel multi-center study, serving as the largest pilot study for BRCA clinical testing in Nigeria to evaluate treatment & patient outcomes.
Study Outcomes
Feasibility of saliva based BRCA1/2 remote genetic testing
Evaluate the feasibility, acceptability, and cost-effectiveness
Patient reported outcome measures
Implement the Multidimensional Impact of Cancer Risk Assessment (MICRA) tool to measure the impact of result disclosure after genetic testing
Prevalence of BRCA1/2 mutation
Determine the proportion of BC patients with BRCA1/ BRCA2 mutations
​
​​
Patient experience
Evaluate patient perceptions and experience post-surgery
Treatment related events
Review of type of surgery, treatment, and oncologic outcomes
95
Enrolled Patients
bottom of page